BMA vs AVAL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 18, 2026

BMA

61.8
AI Score
VS
BMA Wins

AVAL

53.1
AI Score

Investment Advisor Scores

BMA

62score
Recommendation
HOLD

AVAL

53score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BMA AVAL Winner
Forward P/E 3.0979 0 Tie
PEG Ratio 0.4681 0 Tie
Revenue Growth 1.2% 18.6% AVAL
Earnings Growth 3.5% 16.7% AVAL
Tradestie Score 61.8/100 53.1/100 BMA
Profit Margin 9.0% 12.2% AVAL
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY AVAL

Relative Price Performance (Last 90 Days)

BMA 1M: -9.8% · 3M: -30.6% AVAL 1M: -2.0% · 3M: -0.4%

Current Technical Phase

BMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.7%), weak momentum, RSI 38

RSI (14): 38.5 · Price: $64.03

AVAL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 43

RSI (14): 43.3 · Price: $4.80

Fundamentals Snapshot

Metric BMA AVAL
Market Cap — —
Forward P/E 0.0 7.4
Trailing P/E 13.2 12.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 1.0% 1.0%
Operating Margin 0.3% 0.0%
EPS 4.89 0.38
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.